Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up

Go back to Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up
(NASDAQ: CLOV) Delayed: 4.49 +0.03 (0.67%)
Previous Close $4.46    52 Week High
Open $4.53    52 Week Low
Day High $4.57    P/E N/A 
Day Low $4.45    EPS
Volume 1,562,047